University of Glasgow, Glasgow, United Kingdom
Stephen Thomas McSorley , Paul G. Horgan , Donald C McMillan
Background: It is now clear that there is a significant association between the magnitude of the systemic inflammatory response and postoperative complications (Adamina et al. Br J Surg 2015;102(6):590-8). The present study examined the impact of preoperative steroids on the postoperative systemic inflammatory response and complications, following elective surgery for colorectal cancer. Methods: The administration of dexamethasone at induction of anaesthesia was prospectively audited from a cohort of patients who underwent elective, potentially curative surgery for colorectal cancer at a single centre between 2008 and 2013. Results: 286 patients were included, of which the majority were male (161, 57%), over 65 (190, 66%) with colonic (183, 64%) and node negative disease (192, 67%). 114 (40%) received dexamethasone at induction of anaesthesia. There was a significant association (Table 1) between preoperative dexamethasone administration and the proportion of patients breaching established CRP thresholds on postoperative days 2 (190mg/L, 14% vs. 50%, p<0.001), and 3 (170mg/L, 27% vs. 49%, p<0.001) but not 4 (145mg/L, 50% vs. 36%, p=0.658). There was no significant association between preoperative dexamethasone and postoperative complications. Conclusions: The present study suggests that the systemic inflammatory response following surgery for colorectal cancer may be attenuated by preoperative steroids. It remains to be determined whether this will lead to a reduction in postoperative complications.
Outcome | No Dexamethasone | Preoperative Dexamethasone | P |
---|---|---|---|
N | 172 | 114 | - |
POD 2 CRP (median,range,mg/L) | 191 (50-454) | 109 (16-317) | <0.001 |
POD 2 CRP >190mg/L (yes/no) | 84/84 | 16/95 | <0.001 |
POD 3 CRP (median,range,mg/L) | 169 (22-601) | 121 (17-430) | <0.001 |
POD 3 CRP >170 mg/L (yes/no) | 81/84 | 29/79 | <0.001 |
POD 4 CRP (median,range,mg/L) | 118 (13-528) | 119 (20415) | 0.180 |
POD 4 CRP >145 mg/L (yes/no) | 56/99 | 30/60 | 0.658 |
Any complication (yes/no) | 70/102 | 37/77 | 0.158 |
Infective complication (yes/no) | 45/127 | 27/87 | 0.636 |
Anastomotic leak (yes/no) | 8/164 | 3/111 | 0.385 |
POD, postoperative day; CRP, C-reactive protein.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2018 Gastrointestinal Cancers Symposium
First Author: Stephen Thomas McSorley
2023 ASCO Annual Meeting
First Author: Wenliang Li
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Rebecca A Snyder
2021 ASCO Annual Meeting
First Author: Li Jingjing